At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02630 VIGONVITA-B
Closed 11-05 16:08:15
80.300
+0.300
+0.38%
High81.200
Low76.000
Vol84.60K
Open76.000
D1 Closing80.000
Amplitude6.50%
Mkt Cap13.41B
Tradable Cap13.41B
Total Shares167.00M
T/O6.81M
T/O Rate0.05%
Tradable Shares167.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
VIGONVITA-B Repurchases 73,600 H-Shares for HKD 5.69 Million; Treasury Stock Rises to 417,600 Shares
Hong Kong Stock Movement: VIGONVITA-B (02630) Surges Over 4% in Afternoon Trading as Novel Antipsychotic Class 1 Drug VV119 Recently Enters Phase II Clinical Trial
Vigonvita Life Sciences Co Ltd is a China-based company mainly engaged in the discovery, development and commercialization of small molecule drugs. The Company mainly focuses on the fields of neuropsychiatric, reproductive health and viral infection treatment. The Company's product pipeline mainly includes LV232, TPN102, VV119, VV147, TPN171, VV913, VV116, VV261 and VV207. The Company has entered the commercialization stage. The Company primarily operates its businesses in China and Uzbekistan.